Tower Research Capital (TRC)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,426
Closed -$129K 6313
2021
Q1
$129K Buy
3,426
+1,888
+123% +$71.1K ﹤0.01% 2381
2020
Q4
$26K Sell
1,538
-32,907
-96% -$556K ﹤0.01% 3710
2020
Q3
$162K Buy
34,445
+26,610
+340% +$125K ﹤0.01% 2762
2020
Q2
$48K Buy
+7,835
New +$48K ﹤0.01% 3092
2019
Q4
Sell
-6,557
Closed -$25K 4761
2019
Q3
$25K Buy
6,557
+1,183
+22% +$4.51K ﹤0.01% 2323
2019
Q2
$33K Buy
5,374
+5,074
+1,691% +$31.2K ﹤0.01% 1848
2019
Q1
$4K Buy
+300
New +$4K ﹤0.01% 3235
2018
Q4
Sell
-296
Closed -$4K 4604
2018
Q3
$4K Buy
296
+228
+335% +$3.08K ﹤0.01% 3252
2018
Q2
$1K Sell
68
-1,744
-96% -$25.6K ﹤0.01% 3553
2018
Q1
$31K Buy
1,812
+68
+4% +$1.16K ﹤0.01% 1960
2017
Q4
$38K Buy
1,744
+1,533
+727% +$33.4K ﹤0.01% 1550
2017
Q3
$9K Buy
211
+111
+111% +$4.74K ﹤0.01% 3131
2017
Q2
$3K Buy
+100
New +$3K ﹤0.01% 2268
2017
Q1
Sell
-1,123
Closed -$56K 4258
2016
Q4
$56K Buy
1,123
+1,073
+2,146% +$53.5K 0.01% 1366
2016
Q3
$3K Buy
+50
New +$3K ﹤0.01% 2944
2016
Q2
Sell
-114
Closed -$5K 5231
2016
Q1
$5K Buy
+114
New +$5K ﹤0.01% 2783
2015
Q4
Sell
-1,364
Closed -$21K 5320
2015
Q3
$21K Buy
1,364
+862
+172% +$13.3K ﹤0.01% 1703
2015
Q2
$12K Sell
502
-3,278
-87% -$78.4K ﹤0.01% 2562
2015
Q1
$87K Buy
3,780
+2,956
+359% +$68K 0.01% 1009
2014
Q4
$22K Buy
824
+443
+116% +$11.8K ﹤0.01% 1537
2014
Q3
$4K Sell
381
-2,987
-89% -$31.4K ﹤0.01% 3498
2014
Q2
$52K Buy
3,368
+3,308
+5,513% +$51.1K 0.01% 1274
2014
Q1
$1K Buy
+60
New +$1K ﹤0.01% 4252